Alligator Bioscience announces extraordinary shareholder meeting

• Alligator Bioscience will hold an extraordinary general meeting in Lund on Aug. 26, 2026.
• Shareholders will vote on amending the articles of association, including resetting the share capital range.
• The meeting will consider two share capital reductions totaling SEK 122.48 million, partly for loss coverage and partly to transfer to unrestricted equity.
• Investors will be asked to ratify a rights issue of up to 3,140,534,240 units priced at SEK 0.04 per unit, each unit comprising two shares plus TO 15 and TO 16 warrants.
• Board authorizations are also proposed for issues to guarantors and a separate warrant issue to Fenja Capital as part of a loan restructuring.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.